top of page
List of Biomakrers.jpg
Neurodegenerative Diseases and Dementia

Pathology leading to continues neuronal death 

Neurodegenerative diseases are pathophysiological situations that lead to the death of neuronal cells. No cure is available for these disease conditions. 

Early Diagnosis is the Key

Early detection is only way to prevent disease progression 

Sadly, noticeable symptoms of neurodegenerative disease are observed only after a significant loss of neuronal density. As neurons do not have regeneration capacity, it is considered “too late” when the first symptoms are observed.

We Have Advanced Technology

Non-invasive SIMOA based platform

Pre-symptomatic biomarkers associated with neurodegenerative diseases were previously only quantifiable from cerebrospinal fluid. Now with advanced single-molecule based array, we can effectively diagnose disease from blood samples.

ASSAY SERVICES

AlzheimersAwarenessRibbon.jpg

Alzheimers Disease 

Contributes to 75% of totall Dementia cases. Close to 50 million people are effected by Dementia.  Total cost of disease raised to  US $1 trillion  in 2018.

Parkinson Disease.jpg

Parkinsons Disease 

Globally Parkinson Disease affects 6.2 million people and resulted in about 117,400 deaths in 2015. Life expectancy post-diagnosis is between 7 -15 years 

multiple-sclerosis-ribbon-vectorjpg.jpg

Multiple Sclerosis 

Most common inflammatory neurological disease in young adults. Globallly, about 2 million Multiple Sclerosis patients were present in 2016.

Senior Physiotherapy

INTERVENTION THERAPY

Once neurodegeneration is diagnosed before the symptoms are observed. An intervention therapy can drastically improve the life quality of the patient by delaying or inhibiting pathological progression.

WHY IS INTERVENTION THERAPY BETTER?

Neurons lack regeneration capacity

It is known that neuronal cells are unable to regenerate. Therefore, symptomatic neurodegeneration is irreversible.

​

No effective cure

Although, several medical drugs are available for the treatment of neurodegenerative disorders yet none is considered effective.

​

 

Does not solely depend on drugs

Compound based therapeutics are known to cause side effects. Lifestyle interventions if effective are considered superior.

​

WE CAN PROVIDE INDIVIDUALIZED INTERVENTION THERAPY STEPS

ADDITIONAL SERVICES

Anatomical Model

KIDNEY DISEASE

Drug and Syringe

AUTOIMMUNE

Patient on Scale

OBESITY-DIABETES

Foot Muscles Model

INFLAMMATION

Blood Test

LIVER DISEASE

DRUG DISCOVERY COMPANIES

Identification of novel drug efficacy using brain scan technology to identify disease progression is expansive. Blood-based prognostic biomarkers will reduce the net cost of clinical research.

CLINICAL RESEARCH CENTERS

Identification of novel drug efficacy using brain scan technology to identify disease progression is expansive. Blood-based prognostic biomarkers will reduce the net cost of clinical research.

CLIINCAL DIAGNOSTIC CENTERS

Individuals identified at high risk of neurodegenerative disorders may conduct annual checkups for asymptomatic biomarkers to ensure early identification and better treatment.     

PHYSICAL EXAMINATION CLINICS

Individuals identified at high risk of neurodegenerative disorders may conduct annual checkups for asymptomatic biomarkers to ensure early identification and better treatment.     

White Structure

SUBMIT SAMPLES

to our office at

HKSTP

bottom of page